Paper · 10362012
Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.
Sharma M and 7 others. J Cell Physiol, 1999. Cited by 317 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. Papers, record 10362012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10362012
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Muscle Fibers, Skeletal | Major topic |
| Myocardial Infarction | Major topic |
| Myocardium | Major topic |
| Transforming Growth Factor beta | Major topic |
| Animals | |
| Base Sequence | |
| Blotting, Western | |
| Cattle | |
| Conserved Sequence | |
| DNA, Complementary | |
| Disease Models, Animal | |
| Gene Expression Regulation, Developmental | |
| Mammals | |
| Molecular Sequence Data | |
| Muscle, Skeletal | |
| Mutation | |
| Myostatin | |
| RNA, Messenger | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Sequence Homology, Amino Acid | |
| Sheep | |
| Up-Regulation |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References0
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
None in this release.
Cited by138
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 317 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,758,701 | Myostatin-dependent detrusor remodelling mediates contractility impairment in diabetic rats' bladder - a maximal elastance analysis. | J Physiol | 2026 | https://conductscience.org/library/papers/42758701 | PubMed |
| 42,192,415 | Exerkine dysregulation links visceral adiposity to skeletal muscle impairment in end-stage heart failure with reduced ejection fraction: proteomic evidence for a cardio-adipose-muscle axis. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/42192415 | PubMed |
| 42,123,606 | Omega-3 Fatty Acids Attenuate Renal Myostatin Expression and Mitochondrial Alterations Under Uremic Conditions. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42123606 | PubMed |
| 41,731,743 | A High Dose of Short-term Intraperitoneal D-galactose-induced Aging Process in Male Rats. | Ann Afr Med | 2026 | https://conductscience.org/library/papers/41731743 | PubMed |
| 41,423,189 | Emerging Role of Myostatin Inhibitors in the Management of Glucagon-Like Peptide-1-Associated Sarcopenia and Metabolic Disorders. | J Bone Metab | 2025 | https://conductscience.org/library/papers/41423189 | PubMed |
| 41,198,895 | Cardiac rehabilitation influences serum myokine levels in patients after acute coronary syndrome: the randomised CARDIO-REH study. | Sci Rep | 2025 | https://conductscience.org/library/papers/41198895 | PubMed |
| 40,565,321 | Myostatin Modulation in Spinal Muscular Atrophy: A Systematic Review of Preclinical and Clinical Evidence. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565321 | PubMed |
| 40,403,102 | Skeletal Muscle as a Mediator of Interorgan Crosstalk During Exercise: Implications for Aging and Obesity. | Circ Res | 2025 | https://conductscience.org/library/papers/40403102 | PubMed |
| 40,218,995 | An Overview of Sarcopenia: Focusing on Nutritional Treatment Approaches. | Nutrients | 2025 | https://conductscience.org/library/papers/40218995 | PubMed |
| 39,201,422 | Understanding Secondary Sarcopenia Development in Young Adults Using Pig Model with Chronic Pancreatitis. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201422 | PubMed |
1 to 10 of 138
See all 138 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MSTN | 2,660 | PubTator's text mining | https://conductscience.org/library/genes/2660 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10362012
GET https://conductscience.org/api/papers/v1/10362012/cited_by?page=2